Skip to content

TTRX TTRX Book value per share

Book value per share at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$291.77+10.4%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$5.52-72.6%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$1.13+18.5%
PTH
Pelthos Therapeutics Inc.PTHS
$10.60+255%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$6.85-35.3%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$1.47+29.5%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Calculated from TTRX’s reported figures.

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's book value per share?
TTRX (TTRX) reported book value per share of $0.21 in Q1 2026.
How has TTRX's book value per share changed year-over-year?
TTRX's book value per share increased by 582.6% year-over-year, from $0.03 to $0.21.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.